Fanconi Renotubular Syndrome 1: A Patient Guide
At a Glance
Fanconi renotubular syndrome 1 is a rare inherited kidney disorder caused by a GATM gene change. Genetic testing can confirm it after mineral losses, bone symptoms, or problems with growth raise concern. Treatment uses phosphate and active vitamin D, with checks of bone health and kidney function.
Fanconi Renotubular Syndrome 1 (FRTS1) is a rare genetic condition that fundamentally changes how your kidneys manage the body’s “building blocks.” In a healthy kidney, tiny structures called proximal tubules act as recycling centers, reclaiming vital minerals, sugars, and proteins before they can be lost in the urine. For those with FRTS1, a mutation in the GATM gene causes proteins to clump together within the energy-producing parts of these tubule cells, making it difficult for them to do their job [1]. As a result, the kidneys begin to “leak” essential substances like phosphate, potassium, and bicarbonate that the body needs to maintain strong bones and steady energy levels [2].
Understanding this diagnosis starts with clearing up a very common point of confusion: although the names are similar, Fanconi Renotubular Syndrome 1 is entirely distinct from Fanconi Anemia. While Fanconi Anemia is a complex blood and DNA repair disorder, FRTS1 is specifically a disorder of the kidney tubules and bone metabolism [1]. Because the symptoms—such as bone pain, bowing of the legs, or growth delays—often mirror other common conditions like simple Vitamin D deficiency, getting to the right answer often requires specialized genetic testing to confirm the GATM variant [3]. Knowing exactly which condition you are managing is the first step toward building a targeted care plan that protects your long-term health.
Living with FRTS1 is largely a journey of balance and consistent support. Since there is currently no way to “fix” the underlying genetic mutation, treatment focuses on replacing the specific minerals and nutrients the kidneys are losing to reduce deficiency-related complications [4]. This involves an individualized daily routine of supplements, such as oral phosphate and active Vitamin D, alongside regular monitoring of your blood and urine levels to ensure your bones stay strong and your metabolism stays balanced. While this daily management is highly effective for protecting bone health, its long-term effect on preventing GATM-related chronic kidney disease (CKD) progression is still being studied [2].
Although FRTS1 is exceptionally rare, you do not have to navigate it alone. Because the condition’s progression is highly variable, having a dedicated care team—including a nephrologist and a geneticist—is essential for tailoring treatment to your specific needs. Research into GATM-associated disorders is expanding every year. You are the most important member of your care team, and being informed is your greatest tool in protecting your or your child’s future [5].
In this guide
6 chapters
Understanding Fanconi Renotubular Syndrome 1 (FRTS1)
Learn what Fanconi Renotubular Syndrome 1 (FRTS1) means, including GATM genetics, kidney losses, rickets, treatment, monitoring, long-term outlook for families.
Symptoms, Warning Signs, and When to Seek Urgent Care
Learn the symptoms of Fanconi Renotubular Syndrome 1, daily management steps, same-day warning signs, and emergency symptoms linked to electrolyte problems.
The Diagnostic Process and Avoiding Misdiagnoses
Learn how Fanconi Renotubular Syndrome 1 is diagnosed, which kidney tests identify proximal tubule leaks, and how genetic testing separates look-alike conditions
Genetics, Inheritance, and Subtypes of FRTS
Learn how FRTS1 affects the GATM gene, follows autosomal dominant inheritance, varies among relatives, and differs from Fanconi Renotubular Syndrome subtypes.
Standard of Care Treatment and Day-to-Day Management
Learn how Fanconi renotubular syndrome 1 is managed with phosphate, active vitamin D, potassium, and monitoring to protect kidney and bone health over time.
Long-Term Monitoring and Prognosis
Learn how Fanconi renotubular syndrome 1 affects long-term kidney health, what monitoring involves, and how eGFR, bone health, and treatment guide care.
Common questions in this guide
What is Fanconi renotubular syndrome 1?
Is Fanconi renotubular syndrome 1 the same as Fanconi anemia?
What symptoms might a child with FRTS1 have?
How is FRTS1 diagnosed?
How is Fanconi renotubular syndrome 1 treated?
Which specialists should care for someone with FRTS1?
Can FRTS1 affect kidney function over time?
Get notified when new evidence is published on Fanconi renotubular syndrome 1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (5)
- 1
Complex phenotype in Fanconi renotubular syndrome type 1: Hypophosphatemic rickets as the predominant presentation.
Li CY, Sun Y, Guo WC, et al.
Clinica chimica acta; international journal of clinical chemistry 2024; (561()):119812 doi:10.1016/j.cca.2024.119812.
PMID: 38876250 - 2
Genetic Screening of Patients With Inherited Fanconi Syndrome.
Inoki Y, Sakakibara N, Yamamoto A, et al.
Kidney international reports 2026; (11(7)):106576 doi:10.1016/j.ekir.2026.106576.
PMID: 42282999 - 3
Inherited Fanconi renotubular syndromes: unveiling the intricacies of hypophosphatemic rickets/osteomalacia.
Ragate DC, Memon SS, Karlekar M, et al.
Journal of bone and mineral metabolism 2024; (42(2)):155-165 doi:10.1007/s00774-023-01490-3.
PMID: 38310177 - 4
Fanconi Syndrome.
Foreman JW
Pediatric clinics of North America 2019; (66(1)):159-167 doi:10.1016/j.pcl.2018.09.002.
PMID: 30454741 - 5
Genetic Testing in the Pediatric Nephrology Clinic: Understanding Families' Experiences.
Nevin SM, McLoone J, Wakefield CE, et al.
Journal of pediatric genetics 2022; (11(2)):117-125 doi:10.1055/s-0040-1721439.
PMID: 35769952
This page provides general information about Fanconi renotubular syndrome 1 and does not replace medical advice. A nephrologist and geneticist should interpret your or your child's test results and treatment plan.